research article
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration - Additional information regarding baseline lesion composition's impact on vision outcomes - TAP report No. 3
To explore how baseline lesion composition influenced vision outcomes in patients with age-related macular degeneration (AMD) undergoing photodynamic therapy with verteporfin (Visudyne) for subfoveal choroidal neovascularization (CNV) in the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy Investigation.
Type
research article
PubMed ID
12427056
Author(s)
Bressler, Neil M.
Arnold, Jennifer
Benchaboune, Mustapha
Blumenkranz, Mark S.
Fish, Gary E.
Gragoudas, Evangelos S.
Lewis, Hilel
Schmidt-Erfurth, Ursula
Slakter, Jason S.
Bressler, Susan B.
Date Issued
2002
Publisher
Published in
Volume
120
Issue
11
Start page
1443
End page
1454
Subjects
Editorial or Peer reviewed
REVIEWED
Written at
EPFL
Available on Infoscience
July 20, 2007
Use this identifier to reference this record